iCover covered stents used as bridging stents during fenestrated endovascular repair for complex abdominal aortic aneurysms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

fenCo is a prospective, multicentre European study that implants the iCover balloon-expandable covered stent as a bridging stent into reno-visceral target vessels during fenestrated endovascular aortic repair (fEVAR). Participating vascular centers will place iCover stents through fenestrations aligned with target vessel orifices and follow patients with clinical and imaging assessments. Key outcomes include procedural success, stent patency, renal function, endoleak rates, and device-related complications. The protocol requires adherence to the Instructions for Use of the chosen fenestrated endograft systems and captures data to document safety and performance of the device.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient suitable for treatment of a juxta, para-renal, suprarenal or thoracoabdominal aneurysm with a fenestrated endoprosthesis in accordance with current indications and guidelines for the management of abdominal aortic aneurysms (aneurysm \> 5 centimetres for women and \> 5.5 centimetres for men and/or growth \> 5 mm in 6 months or 1 centimetre in 1 year).
2. The fenestrated endograft must be designed in a way that positions the fenestrations directly in front of the orifice of the target vessel, ensuring that the distance between the fenestration and the orifice of the target vessel does not exceed 5 mm.
3. Anatomy and patient strictly in accordance with the Instructions For Use (IFU) of the fenestrated endograft chosen to be implanted:

   1. Cook Medical: Zenith Fenestrated AAA Endovascular Graft
   2. Terumo Aortic: TREO and Anaconda Fenestrated Stent Grafts
   3. JOTEC (part of Artivion): E-xtra design engineering.
4. Additional iCover stent, if necessary, could be placed in the same target artery (2 iCovers stents max as bridging stent for each fenestration).
5. Landing zone in the target vessel of at least 10 mm.
6. Target arteries (renal arteries, superior mesenteric artery, celiac trunk) with a diameter between 5 and 10 mm.
7. Angulation of the aorta at the level of the target vessels \< 45 degrees.
8. No early significant branching from the target vessel with a potential risk of coverage and subsequent significant risk of target organ infarctions.
9. Age \> 55 years.
10. Patient having notified his consent to this study and willing to comply with specified follow-up evaluations at the specified times.
11. Patient affiliated to or benefiting from a social security system.
12. Patient with life expectancy \> 12 months.

Exclusion Criteria:

1. Patients contraindicated for anti-platelet therapy.
2. Patients with uncontrolled haematological disorders or heparin-induced thrombocytopenia.
3. Chronic or acute aortic dissection.
4. Patients refusing treatment.
5. Patients who are pregnant or wish to become pregnant.
6. Patients scheduled for major or life-saving surgery within 30 days of the fenestrated stent procedure.
7. Patients considered hemodynamically unstable or requiring emergency treatment.
8. Patients with severe arteriopathy leading to adverse outflow, which may impair bridging stent patency on the targeted artery.
9. Thrombus in the aortic sealing zone and target arteries with thickness \> to 3 mm.
10. Stenosis (\>50%) or occlusion of target arteries or distal disease resulting in poor iCover stent outflow.
11. Patients allergic to stent materials (L605) and/or PTFE.
12. Patients requiring a hybrid aortic technique with branches, semibranches or chimneys.
13. Patient who has been implanted with any stent type or brand other than iCover as a bridging stent in any target artery.
14. Patients with infectious/mycotic aneurysms.
15. Angulation between renal artery and aortic wall \< 30 degrees.
16. Patients with complex iliac accesses out the IFUs of the fenestrated endograft chosen to be implanted (COOK Medical / Terumo Aortic/Jotec-Artivion) with the iCover Bridging stent.
17. Patient is currently participating in another investigational drug or device study that has not completed the entire follow up period that may interfere with the results of this study.
18. Myocardial infarction or stroke within 3 months prior to the procedure.
19. Patients with an unstable angina pectoris or heart insufficiency NYHA 3 or 4.
20. Patients with ASA classification 5 or higher.
21. Patients with physician modified endografts or in situ laser FEVAR.

Where it's running

• CHU BORDEAUX-Hopital Tripode
  Bordeaux, France Recruiting
• Imelda Ziekenhuis
  Bonheiden, Belgium Not yet recruiting
• Zol Genk
  Genk, Belgium Not yet recruiting
• Maria Middelares GENT
  Ghent, Belgium Not yet recruiting
• Uz Gent
  Ghent, Belgium Not yet recruiting
• Grand hopital Saint Josep
  Gilly, Belgium Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quality of life after open repair for complex abdominal aortic aneurysms

  This project will use the SF-36 questionnaire to see how open surgical repair affects quality of life over one year in adults having open surgery for complex abdominal aortic aneurysms.

  Recruiting Ente Ospedaliero Cantonale, Bellinzona · Lucerne and 1 other locations · NCT07580443

• BAO-G technique for repairing complex thoracoabdominal and abdominal aortic aneurysms

  This study will try the BAO-G endovascular technique, which uses off-the-shelf iliac branched devices to rebuild visceral branches in patients with complex thoracoabdominal or abdominal aortic aneurysms who are candidates for endovascular repair.

  Recruiting at 11 sites Peking Union Medical College Hospital · Beijing, Beijing Municipality and 10 other locations · NCT07141251

• Using modified endovascular grafts to treat complex aortic aneurysms

  This study is testing if specially modified grafts can safely repair complex aortic aneurysms in high-risk patients who can’t have regular surgery.

  Recruiting Hartford Hospital · Hartford, Connecticut · NCT06834607

• Repair of complex aortic aneurysms using custom devices

  This study is testing custom-made devices to see if they can safely and effectively treat complex aortic aneurysms in patients who can't use standard options, especially those at high risk or with conditions like Marfan syndrome.

  Recruiting University of Massachusetts, Worcester · Worcester, Massachusetts · NCT02050113

• Physician-modified endograft repair for complex abdominal and thoracoabdominal aortic aneurysms in high-risk patients

  This study will try physician-modified endografts to repair complex abdominal and thoracoabdominal aortic aneurysms in patients who are too high-risk for open surgery and do not meet criteria for currently approved devices.

  Recruiting Baylor College of Medicine · Houston, Texas · NCT07224230

• Monitoring patients with abdominal aortic aneurysms before and after surgery

  This study is trying to see how well a new imaging technology works for monitoring patients with abdominal aortic aneurysms before and after they have surgery.

  Recruiting at 8 sites ViTAA Medical Solutions · Birmingham, Alabama and 7 other locations · NCT05004051

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.